Rogers (ROG) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
3 Feb, 2026Executive summary
Q4 2024 results met guidance, with sales, gross margin, and adjusted EPS aligning with expectations despite persistent market headwinds, especially in EV/HEV and industrial segments.
Full-year 2024 sales declined 9% year-over-year, mainly due to weakness in industrial and EV/HEV markets, while aerospace and defense sales grew.
Operational excellence and cost-saving initiatives drove robust free cash flow and supported a strong balance sheet.
Significant commercial wins, new product launches, and design wins position the company for future growth as markets recover.
Customers remain cautious on recovery timing in key markets; focus remains on design wins, cost structure, and manufacturing priorities for 2025.
Financial highlights
Q4 2024 net sales were $192.2M, down 8.6% sequentially and 6.1% year-over-year; full-year 2024 net sales were $830.1M, down from $908.4M in 2023.
Q4 gross margin was 32.1%, down from 35.2% in Q3 2024; full-year gross margin was 33.4%.
Q4 adjusted EPS was $0.46; full-year adjusted EPS was $2.72.
Q4 adjusted EBITDA was $23.3M (12.1% margin); full-year adjusted EBITDA was $118.7M (14.3% margin).
Free cash flow for 2024 was $71M; year-end cash and equivalents were $159.8M.
Outlook and guidance
Q1 2025 net sales expected between $180M and $195M, with gross margin guidance of 29.0% to 30.5%.
Q1 2025 adjusted EPS guidance is $0.10 to $0.40, including expected restructuring charges from the Belgium facility wind-down.
2025 capital expenditures projected at $40M to $50M as China expansion completes.
Recovery in key markets anticipated in the second half of 2025, with Q1 as the low point.
Latest events from Rogers
- Q4 sales and margins rose on cost savings; 2026 outlook projects continued growth.ROG
Q4 202518 Feb 2026 - Gross margin and adjusted EPS improved in Q2, with EMS growth offsetting AES softness.ROG
Q2 20242 Feb 2026 - Strong growth in EV and high-tech markets, with margin expansion and global innovation focus.ROG
Stifel 2024 Cross Sector Insight Conference31 Jan 2026 - Earnings beat guidance, but sales fell on weak EV/HEV demand; Q4 outlook remains cautious.ROG
Q3 202418 Jan 2026 - Q1 2025 sales fell but cash rose; Q2 guidance stable despite ongoing tariff risks.ROG
Q1 202527 Dec 2025 - Operational improvements and innovation in high-growth markets drive optimism for H2 recovery.ROG
Gabelli Funds' 16th Annual Specialty Chemicals Symposium19 Dec 2025 - Annual meeting to elect nine directors, ratify PwC, and approve executive pay, with strong governance focus.ROG
Proxy Filing2 Dec 2025 - Director elections, auditor ratification, and say-on-pay up for vote at May 2025 meeting.ROG
Proxy Filing2 Dec 2025 - Q2 2025 saw sequential sales growth, curamikⓇ impairments, and major restructuring.ROG
Q2 202516 Nov 2025